Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma-Reference-Cited by-同舟云学术

Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma

Author:

Chang Chun-Jung¹^ORCID,Yang Yao-Hsu²,Chiu Chiao-Juno³,Lu Li-Chun¹⁴,Liao Chien-Chia³,Liang Cher-Wei⁵⁶,Hsu Chih-Hung¹⁴,Cheng Ann-Lii¹⁴⁷⁸

Affiliation:

1. Graduate Institute of Oncology; National Taiwan University College of Medicine; Taipei Taiwan

2. Department of Pediatrics; National Taiwan University Hospital; Taipei Taiwan

3. Graduate Institute of Immunology, National Taiwan University College of Medicine; Taipei Taiwan

4. Department of Oncology; National Taiwan University Hospital; Taipei Taiwan

5. Graduate Institute of Pathology; National Taiwan University College of Medicine; Taipei Taiwan

6. Division of Pathology; Fu Jen Catholic University Hospital; New Taipei City Taiwan

7. Department of Internal Medicine; National Taiwan University Hospital; Taipei Taiwan

8. National Taiwan University Cancer Center, National Taiwan University College of Medicine; Taipei Taiwan

Funder

Ministry of Science and Technology, Executive Yuan, Taiwan

National Taiwan University Hospital

National Science Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献